CP

Caligan Partners Portfolio holdings

AUM $515M
This Quarter Return
+5.44%
1 Year Return
+70.09%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$165M
AUM Growth
+$165M
Cap. Flow
+$13M
Cap. Flow %
7.92%
Top 10 Hldgs %
99.2%
Holding
12
New
1
Increased
4
Reduced
3
Closed
–

Top Buys

1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
$14.3M
2
EOLS icon
Evolus
EOLS
$1.72M
3
EXEL icon
Exelixis
EXEL
$1.16M
4
ANIK icon
Anika Therapeutics
ANIK
$130K
5
AGIO icon
Agios Pharmaceuticals
AGIO
$14.2K

Top Sells

1
ADMA icon
ADMA Biologics
ADMA
$3.01M
2
EYPT icon
EyePoint Pharmaceuticals
EYPT
$1.09M
3
LAB icon
Standard BioTools
LAB
$210K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LQDA icon
1
Liquidia Corp
LQDA
$2.38B
$72.6M 40.81%
9,243,627
– –
ANIK icon
2
Anika Therapeutics
ANIK
$135M
$18.7M 10.52%
720,291
+5,000
+0.7% +$130K
EXEL icon
3
Exelixis
EXEL
$10.1B
$17.4M 9.79%
910,730
+60,730
+7% +$1.16M
LAB icon
4
Standard BioTools
LAB
$481M
$16.3M 9.19%
8,467,920
-108,879
-1% -$210K
ICPT
5
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$14.3M 8.05%
+1,293,510
New +$14.3M
EOLS icon
6
Evolus
EOLS
$494M
$12.8M 7.2%
1,760,136
+236,652
+16% +$1.72M
VRNA
7
Verona Pharma
VRNA
$9.16B
$3.87M 2.18%
183,064
– –
ADMA icon
8
ADMA Biologics
ADMA
$4.12B
$3.13M 1.76%
847,513
-815,100
-49% -$3.01M
EYPT icon
9
EyePoint Pharmaceuticals
EYPT
$797M
$2.7M 1.52%
310,298
-125,000
-29% -$1.09M
ALIM
10
DELISTED
Alimera Sciences, Inc.
ALIM
$1.4M 0.79%
478,777
– –
SCTL
11
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.18M 0.67%
1,077,268
– –
AGIO icon
12
Agios Pharmaceuticals
AGIO
$2.19B
$137K 0.08%
4,833
+500
+12% +$14.2K